It is established that HCC, despite the wide clinical and morphological heterogeneity, is typically not burdened by a high number of mutations, the most common driver mutations being in the TP53, CTNNB1, and TERT-promoter genes [10, 12]. Here, TP53 is linked to hepatocellular carcinoma.